Coca-Cola Enterprises adds Garry Watts to the board
Mr. Watts most recently served as chief executive officer for the British consumer healthcare products company SSL International. While there, he led the company’s successful turnaround, resulting in its recently-completed sale to Reckitt Benckiser.
Mr. Watts joined SSL International in 2001, where he served as the company’s group finance director before being named CEO in 2004. From 1996 to 1999, he was the group finance director of Medeva plc. Following Medeva’s merger with Celltech in 1999, he became chief executive officer of Celltech Medeva, the manufacturing, selling and marketing division of Celltech Group.
Prior to that, Mr. Watts held various roles at KPMG, including partner and national head of KPMG’s healthcare and life sciences practice. Mr. Watts will serve on the Finance and Audit Committees of CCE’s board of directors.
Mr. Watts currently serves on the board of directors at Stagecoach Group, where he is senior independent director and chairman of the Audit Committee, and previously served on the boards of Celltech Group, Medeva and Protherics. From 1991 to 2008, Mr. Watts was a non-executive member of the United Kingdom’s Medicines and Healthcare Products Regulatory Agency Board and chairman of its Audit and Risk Committee. ■